Generate Biomedicines, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-03-31 |
|---|---|---|
Revenue | $7,224 | $8,818 |
Gross Profit | 3,951 | |
EBITDA | -60,838 | |
EBIT | -64,111 | |
Net Income | -61,446 | -41,685 |
Net Change In Cash | 7,224 | 8,818 |
Free Cash Flow | -84,169 | -53,927 |
Cash | 160,575 | |
Basic Shares | 128,192 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 |
|---|---|---|
Revenue | $31,893 | $20,459 |
Gross Profit | 31,893 | 20,459 |
EBITDA | -208,488 | -163,705 |
EBIT | -221,666 | -179,054 |
Net Income | -203,154 | -173,771 |
Net Change In Cash | 31,893 | 20,459 |
Free Cash Flow | -204,133 | -121,197 |
Cash | 121,650 | 176,269 |
Basic Shares | 50,088 | 127,450 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$1.07 |